Strata Critical Medical, Inc. Earnings Per Share Disclosure
Year Ended December 31, | ||||||||||||||
| 2024 | 2023 | |||||||||||||
| Basic and dilutive loss per common share: | ||||||||||||||
| Net loss attributable to Blade Air Mobility, Inc. | $ | (27,307) | $ | (56,076) | ||||||||||
| Total weighted-average basic common shares outstanding | 77,499,423 | 73,524,476 | ||||||||||||
| Net loss income per common share: | ||||||||||||||
| Basic and diluted loss per common share | $ | (0.35) | $ | (0.76) | ||||||||||
Year Ended December 31, | ||||||||||||||
| 2024 | 2023 | |||||||||||||
| Warrants to purchase shares of common stock | 14,166,644 | 14,166,644 | ||||||||||||
| Options to purchase shares of common stock | 5,124,516 | 7,217,074 | ||||||||||||
Restricted shares of common stock | 9,286,110 | 5,259,982 | ||||||||||||
| Total potentially dilutive securities | 28,577,270 | 26,643,700 | ||||||||||||
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.